Patents by Inventor Guillermo Basilico

Guillermo Basilico has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant fusion-enzyme with repair activity on DNA lesions produced by UV radiation; its usage, preparation and purification method; a method to stabilize enzymes and treatment methods
    Patent number: 7927603
    Abstract: A recombinant fusion enzyme repairs DNA damaged by UV radiation, and the method of preparing recombinant fusion enzyme. The method includes the fusion of an enzyme coded by a gene isolated from Micrococcus luteus and a stabilizing peptide having the amino acid sequence described in SEQ ID NO 2. A treatment method intended to repair DNA lesions produced in cells exposed to UV radiation and to repair cell anomalies or lesions produced by sun exposure. Such treatment consists of the administration of a effective amount of recombinant fusion enzyme, or a vector containing the gene coding to the recombinant fusion enzyme, to patients requiring such treatment.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: April 19, 2011
    Inventors: Nestor Alberto Kerner, Guillermo Basílico, Mauricio Seigelchifer
  • Recombinant Fusion-Enzyme with Repair Activity on DNA Lesions Produced by UV Radiation; Its Usage, Preparation and Purification Method; A Method to Stabilize Enzymes and Treatment methods
    Publication number: 20070280923
    Abstract: A recombinant fusion enzyme repairs DNA damaged by UV radiation, and the method of preparing recombinant fusion enzyme. The method includes the fusion of an enzyme coded by a gene isolated from Micrococcus luteus and a stabilizing peptide having the amino acid sequence described in SEQ ID No 2. A treatment method intended to repair DNA lesions produced in cells exposed to UV radiation and to repair cell anomalies or lesions produced by sun exposure. Such treatment consists of the administration of a effective amount of recombinant fusion enzyme, or a vector containing the gene coding to the recombinant fusion enzyme, to patients requiring such treatment.
    Type: Application
    Filed: May 17, 2007
    Publication date: December 6, 2007
    Inventors: Nestor Alberto Kerner, Guillermo Basilico, Mauricio Seigelchifer